-+ 0.00%
-+ 0.00%
-+ 0.00%

CALIDI BIOTHERAPEUTICS - TARGETS FIRST PATIENT DOSING IN CLD-401 PHASE I TRIAL IN Q1 2027

路透·07/21/2026 12:00:04

登录查看新闻详情